Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Distribution of clinical candida species and their antifungal susceptibility

Show simple item record

dc.contributor.author Burduniuc, Olga
dc.contributor.author Bîrcă, Ecaterina
dc.contributor.author Burduniuc, Aurelia
dc.contributor.author Grumeza, Maria
dc.contributor.author Bivol, Maria
dc.date.accessioned 2021-01-05T13:22:20Z
dc.date.available 2021-01-05T13:22:20Z
dc.date.issued 2020
dc.identifier.citation BURDUNIUC, Olga, BÎRCĂ, Ecaterina, BURDUNIUC, Aurelia, GRUMEZA, Maria, BIVOL, Maria. Distribution of clinical candida species and their antifungal susceptibility = Distribuţia speciilor clinice de candida şi sensibilitatea acestora la antifungice. In: Congresul consacrat aniversării a 75-a de la fondarea USMF „Nicolae Testemițanu”, 21-23 octombrie 2020: Abstract book. Chișinău: [s. n.], 2020, p. 167. en_US
dc.identifier.uri https://stiinta.usmf.md/sites/default/files/inline-files/Abstract%20Book.%20CULEGERE%20DE%20REZUMATE%20.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/14588
dc.description.abstract Background. Opportunistic infections of fungal origin are a challenge of the 21st century. The correct identification of Candida species involved in human mycoses and testing of susceptibility to antifungals are key elements in the management of these infections, especially in the case of antifungal resistance Objective of the study. Analysis of the distribution and antifungal sensitivity patterns of Candida species isolated from various pathological samples during the years 2017-2018. Material and Methods. A descriptive study of Candida species distribution and antifungal susceptibility profile was performed. Identification of isolated Candida species was performed by the MALDI-TOF system, and antifungal susceptibility profiles by Fungitest (Bio-Rad SDP Paris, France). Results. Of the 83 recovered strains, Candida non albicans species predominated - 50.6% and Candida albicans constituted 49.4%. The most common species of the Candida non albicans, were C.parapsilosis (25.3%), C.glabrata (12.0%) and C.krusei (4.8%). Analysis of antifungal susceptibility testing of the recovered strains was found that 95.2% Candida spp. were susceptible to 5-fuorocytosine and 94.0% to ketoconazole and intermediate susceptibility to miconazole 34.9%, itraconazole 15.7%. Candida species were resistant to miconazole in 15.7% of the cases, and in 14.5% of cases each to amphotericin B and fluconazole, 9.6% to itraconazole. Conclusion. C.albicans is the most frequently isolated fungal species, but there is also an increase share of non-albicans Candida species such as C.parapsilosis. Introducere. Infecțiile oportuniste de origine fungică sunt o provocare a secolului XXI. Identificarea corectă a speciilor Candida implicate în dezvoltarea micozelor umane, determinarea sensibilității la antifungice sunt elemente cheie în gestionarea acestor infecții, în special în cazul rezistenței antifungice. Scopul lucrării. Analiza distribuţiei și patternurilor de sensibilitate la antifungice a speciilor de Candida izolate din diverse prelevate patologice pe parcursul anilor 2017-2018. Material și Metode. A fost realizat un studiu descriptiv al distribuției speciilor de Candida și al profilului de sensibilitate la antifungice. Identificarea speciilor de Candida izolate a fost realizată prin sistemul MALDI-TOF, iar profilurile de susceptibilitate antifungică prin Fungitest (Bio-Rad SDP Paris, Franta). Rezultate. Din 83 tulpini recuperate, au predominat speciile Candida non albicans cu 50,6%, iar Candida albicans a constituit 49,4%. Din speciile de Candida non albicans, cele mai frecvente au fost C.parapsilosis (25,3%), C.glabrata (12,0%) şi C.krusei (4,8%). Analizând rezultatele testării către preparatele antifungice a tulpinilor recuperate, s-a observat că 95,2% izolatele au fost sensibile la 5- fuorocytosina și 94,0% la ketoconazol. Speciile de Candida au fost rezistente la miconazol în 15,7% cazuri, iar în câte 14,5% din cazuri fiecare la amfotericină B și fluconazol, 9,6% la itraconazol. Concluzii. C.albicans reprezintă specia fungică cel mai frecvent izolată, însă se observă și creșterea ponderii speciilor de Candida non-albicans, precum C.parapsilosis. Speciile de Candida au fost rezistente la miconazol, amphotericină B și fluconazol. en_US
dc.publisher Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova en_US
dc.subject Candida non albicans en_US
dc.subject Candida albicans en_US
dc.subject antifungal agents en_US
dc.subject mycoses en_US
dc.title Distribution of clinical candida species and their antifungal susceptibility en_US
dc.title.alternative Distribuţia speciilor clinice de candida şi sensibilitatea acestora la antifungice en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics